ENDO 2025 12 - 15 July 2025

Long-term safety and efficacy of somapacitan in short children born small for gestational age: 4-year results from a global phase 2 trial

Authors :

Anders Juul^1,2; Michael Højby³; Masanobu Kawai⁴; Agnès Linglart⁵; Jun Mori6, Nehama Zuckerman-Levin⁷; Philippe Backeljauw⁸; on behalf of the REAL 5 study group

Affiliations

View Details Hide Details

Download .PDF

Keywords

Rare Endocrine Disorder

Congress poster

Somatropin

Search Science Hub

Are you a healthcare professional?

Long-term safety and efficacy of somapacitan in short children born small for gestational age: 4-year results from a global phase 2 trial